Understanding clinical trials in migraine

por Tfelt-Hansen, P.
Publicado 2006

EHMTI-0016. Examples of problematic use of references in the headache literature. A problem for readers, authors, referees, and editors ?

por Tfelt-Hansen, P
Publicado 2014

EHMTI-0022. Pharmacokinetic variability of drugs used for prophylactic treatment in migraine

por Pavbro, P, Tfelt-Hansen, P
Publicado 2014

EHMTI-0368. Treatment of migraine attacks as suggested by Dr. John R. Graham in 1955. A historical analysis with current implications

por Tfelt-Hansen, P, Loder, E
Publicado 2014

EHMTI-0021. The possible effect of telmisartan on the blood-brain barrier transport of verapamil

por Saaby, PL, Tfelt-Hansen, P
Publicado 2014

EHMTI-0120. Are the IHS’ recommendations for evaluation and registration of adverse events in drug trials in migraine being followed ?

por Tfelt-Hansen, P, Kauffmann, J
Publicado 2014

Intracranial hemodynamics during intravenous infusion of glyceryl trinitrate

por Iversen, H. K., Holm, S., Friberg, L., Tfelt-Hansen, P.
Publicado 2008

The importance of co-morbidity and environmental risk factors for the development of migraine

por Le, H, Tfelt-Hansen, P, Skytthe, A, Kyvik, KO, Olesen, J
Publicado 2013

Treatment with sumatriptan 50 mg in the mild phase of migraine attacks in patients with infrequent attacks: a randomised, double-blind, placebo-controlled study

por Tfelt-Hansen, P., Bach, F. W., Daugaard, D., Tsiropoulos, I., Riddersholm, B.
Publicado 2006

Involvement of calcitonin gene-related peptide in migraine: regional cerebral blood flow and blood flow velocity in migraine patients

por Lassen, L. H., Jacobsen, V. B., Haderslev, P. A., Sperling, B., Iversen, H. K., Olesen, J., Tfelt-Hansen, P.
Publicado 2008